Clinical Trial Update: A Study to Find a Suitable Dose of Exl-111 for Further Research [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is being conducted to determine a suitable dose of Exl-111 for allergic diseases, and the study is currently recruiting. Exl-111 is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases

Drugs mentioned

• Exl-111

Snippet

Sponsor: Excellergy Inc. | Conditions: Allergic Disease | Phase 1 | Status: RECRUITING